Newly Approved Drug Therapies (553): Luxiq (betamethasone valerate) Foam, Connetics Corporation

Description of Medical Areas

About the FDA Approved Listings

Drugs Approved by the FDA

Drug Name: Luxiq (betamethasone valerate) Foam

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Connetics Corporation
Approval Status: Approved June 1999
Treatment for: Dermatology

General Information

Luxiq (betamethasone valerate) Foam has been approved for the treatment of dermatoses of the scalp.

Back to Drug Listing

Drug listing last updated on June 20, 2008

Patient Resources: [ Trial Listing ] [ Notification Services ] [ Drug Directories ]
[ About Clinical Research ] [ Patient Resources ] [ Patient Bookstore ]
Professional Resources: [ Research Center Profiles ] [ Industry Provider Profiles ] [ Jobs in Clinical Research ]
[ Industry News ] [ Professional Resources ] [ Professional Bookstore ]
General: [ Search ] [ Site Map ] [ Your Privacy ] [ CW World ] [ Home ]